You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ophthalmic Solutions

Showing 51 - 75 of 2,869
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allergic Conjunctivitis Trial in United States (Reproxalap Ophthalmic Solution (0.25%), Reproxalap Ophthalmic Solution (0.5%),

Completed
  • Allergic Conjunctivitis
  • Reproxalap Ophthalmic Solution (0.25%)
  • +2 more
  • Phoenix, Arizona
  • +6 more
Oct 30, 2019

Dry Eye, Dry Eye Syndromes Trial in Memphis (Reproxalap Ophthalmic Solution (0.25%), Vehicle Opthalmic Solution)

Completed
  • Dry Eye
  • Dry Eye Syndromes
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Opthalmic Solution
  • Memphis, Tennessee
    University Clinical Health
Mar 28, 2022

Presbyopia, Near Vision, Miosis Trial in China (Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine ophthalmic

Not yet recruiting
  • Presbyopia
  • +3 more
  • Aceclidine+Brimonidine combination ophthalmic solution
  • +2 more
  • Wenzhou, Zhejiang, China
  • +18 more
Sep 19, 2023

Ptosis, Eyelid, Conjunctiva Inflamed, Eye Manifestations Trial in Miami (Oxymetazoline HCl 0.1% ophthalmic solution, Placebo)

Active, not recruiting
  • Ptosis, Eyelid
  • +2 more
  • Oxymetazoline hydrochloride 0.1% ophthalmic solution
  • Placebo
  • Miami, Florida
    University of Miami Bascom Palmer Eye Institute
May 11, 2022

Dry Eye, Dry Eye Disease, Kerato Conjunctivitis Sicca Trial in Catanzaro (Hydroxypropyl methylcellulose eye drops)

Completed
  • Dry Eye
  • +2 more
  • Hydroxypropyl methylcellulose eye drops
  • Catanzaro, CZ, Italy
    Azienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 11, 2023

Dry Eye, Dry Eye Disease, Kerato Conjunctivitis Sicca Trial in Catanzaro (Distilled waters based eye drops)

Completed
  • Dry Eye
  • +2 more
  • Distilled waters based eye drops
  • Catanzaro, CZ, Italy
    Azienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 11, 2023

Neurotrophic Keratitis Trial in United States (cenegermin-bkbj)

Completed
  • Neurotrophic Keratitis
  • San Diego, California
  • +4 more
Apr 11, 2022

Open Angle Glaucoma Trial in Albury, Melbourne (ONL1204 Ophthalmic solution (Dose A), ONL1204 Ophthalmic solution (Dose B), Sham

Not yet recruiting
  • Open Angle Glaucoma
  • ONL1204 Ophthalmic solution (Dose A)
  • +2 more
  • Albury, New South Wales, Australia
  • +1 more
Dec 6, 2021

Presbyopia, Near Vision, Miosis Trial in Chandler, Glendale (Aceclidine+Brimonidine combination ophthalmic solution, Placebo,

Recruiting
  • Presbyopia
  • +3 more
  • Aceclidine+Brimonidine combination ophthalmic solution
  • +2 more
  • Chandler, Arizona
  • +1 more
Mar 2, 2023

Dry Eye Trial in Durham (VVN001 Ophthalmic Solution 1%, VVN001 Ophthalmic Solution 5%, Vehicle)

Completed
  • Dry Eye
  • VVN001 Ophthalmic Solution 1%
  • +2 more
  • Durham, North Carolina
    Lexitas
Jan 31, 2022

Mydriasis, Dilation Trial in Longwood, Athens (Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle)

Completed
  • Mydriasis
  • Dilation
  • Phentolamine Ophthalmic Solution 0.75%
  • Phentolamine Ophthalmic Solution Vehicle
  • Longwood, Florida
  • +1 more
Jun 20, 2022

Presbyopia, Refractive Errors, Eye Diseases Trial in United States (Aceclidine+Brimonidine combination ophthalmic solution,

Completed
  • Presbyopia
  • +2 more
  • Aceclidine+Brimonidine combination ophthalmic solution
  • +2 more
  • Glendale, California
  • +4 more
Oct 18, 2022

Presbyopia, Near Vision, Miosis Trial in Newport Beach (Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine,

Not yet recruiting
  • Presbyopia
  • +3 more
  • Aceclidine+Brimonidine combination ophthalmic solution
  • +2 more
  • Newport Beach, California
    Site #201
Feb 6, 2023

Dry Eye Trial in Andover (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Completed
  • Dry Eye
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Andover, Massachusetts
    Andover Eye Associates
Dec 8, 2021

Ocular Surface Disease Trial in Needham (Restasis)

Recruiting
  • Ocular Surface Disease
  • Needham, Massachusetts
    BostonSight
Mar 6, 2022

Dry Eye Syndromes, Computer Vision Syndrome, Asthenopia Trial in Beijing (Diquafosol)

Recruiting
  • Dry Eye Syndromes
  • +2 more
  • Beijing, Beijing, China
    Peking University Third Hospital
May 31, 2022

Presbyopia, Refractive Error, Near Vision Trial in Glendale (Aceclidine + Brimonidine, Aceclidine, Brimonidine)

Recruiting
  • Presbyopia
  • +4 more
  • Aceclidine + Brimonidine
  • +2 more
  • Glendale, California
    Site #101
Jan 10, 2023

Mydriasis, Dilation Trial in United States (Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle)

Completed
  • Mydriasis
  • Dilation
  • Phentolamine Ophthalmic Solution 0.75%
  • Phentolamine Ophthalmic Solution Vehicle
  • Newport Beach, California
  • +14 more
Jun 20, 2022

Dry Eye Trial in Andover (MIM-D3 Ophthalmic Solution, Placebo Ophthalmic Solution)

Completed
  • Dry Eye
  • MIM-D3 Ophthalmic Solution
  • Placebo Ophthalmic Solution
  • Andover, Massachusetts
    Ora, Inc.
Aug 15, 2019

Open Angle Glaucoma or Ocular Hypertension Trial in Shanghai (OPC-1085EL, 0.005% Latanoprost)

Recruiting
  • Open Angle Glaucoma or Ocular Hypertension
  • Shanghai, China
    Eye & ENT Hospital of Fudan University
Oct 14, 2022

Normal Tension Glaucoma, Low-Tension Glaucoma, Bilateral, Low-Tension Glaucoma, Unspecified Eye Trial in Seoul, Manila (QLS-111

Not yet recruiting
  • Normal Tension Glaucoma
  • +3 more
  • QLS-111 ophthalmic solution, (0.015%)
  • +2 more
  • Seoul, Korea, Republic of
  • +1 more
Sep 6, 2023

Glaucoma, Glaucoma, Open-Angle, Glaucoma; Drugs Trial in New Orleans (brimonidine tartrate ophthalmic solution 0.025%, sterile

Not yet recruiting
  • Glaucoma
  • +5 more
  • brimonidine tartrate ophthalmic solution 0.025%
  • sterile balanced saline solution
  • New Orleans, Louisiana
    Tulane University Medical Center
Apr 4, 2022

Dry Eye Disease Trial in Waterloo (0.09% cyclosporine A ophthalmic solution)

Recruiting
  • Dry Eye Disease
  • 0.09% cyclosporine A ophthalmic solution
  • Waterloo, Ontario, Canada
    University of Waterloo
Jul 13, 2023

Dry Eye Disease Trial in Andover, Raynham, Memphis (ST-100 Ophthalmic Solution, Placebo Ophthalmic Solution)

Completed
  • Dry Eye Disease
  • ST-100 Ophthalmic Solution
  • Placebo Ophthalmic Solution
  • Andover, Massachusetts
  • +2 more
Feb 22, 2022

Mydriasis, Dilation Trial in United States (Phentolamine Mesylate Ophthalmic Solution 1%, Phentolamine Mesylate Ophthalmic

Completed
Has Results
  • Mydriasis
  • Dilation
  • Phentolamine Mesylate Ophthalmic Solution 1%
  • Phentolamine Mesylate Ophthalmic Solution Vehicle (Placebo)
  • Pittsburg, Kansas
  • +3 more
Aug 11, 2022